Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations.
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resou
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh